Mira Pharmaceuticals Reports Weight and Fat Reduction With Oral SKNY-1 in Obese Mice
Mira Pharmaceuticals reported weight and fat reduction with oral SKNY-1 in obese mice.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Mira Pharmaceuticals Reports Weight and Fat Reduction With Oral SKNY-1 in Obese Mice
The company reported weight and fat reduction with oral SKNY-1 in obese mice.
Mira Pharmaceuticals Reports Weight and Fat Reduction With SKNY-1 in Obese Mice
Mira Pharmaceuticals reported weight and fat reduction with oral SKNY-1 in obese mice.
MIRA Pharmaceuticals Reports SKNY-1 Weight and Fat Reduction in Obese Mice
MIRA Pharmaceuticals reported that oral SKNY-1 significantly reduced weight and fat in obese mice, with favorable lean-mass and weight-regain findings versus semaglutide.